Key result
Adrenomedullin heterozygote knockout mice exhibited more severe cardiac hypertrophy and renal dysfunction after Angiotensin II infusion compared to wild-type mice.
Why the study?
Does endogenous adrenomedullin deficiency exacerbate angiotensin II-induced cardiac hypertrophy and renal damage in mice?
Does endogenous adrenomedullin deficiency exacerbate angiotensin II-induced cardiac hypertrophy and renal damage in mice?
Endogenous adrenomedullin plays a critical protective role against angiotensin II-induced cardiac hypertrophy and renal dysfunction in a mouse model.
Answers are grounded in this paper and cite their sources.
Supports protective role of endogenous adrenomedullin against Ang II injury; hypothesis-generating for human therapeutic applications.
Adrenomedullin (AM) is a potent vasodilating and natriuretic peptide that is thought to play important roles in cardiovascular function. Whether or not AM is involved in the development of cardiac hypertrophy and renal damage remains controversial. In the present study, using heterozygote knockout mice of the AM gene (AM +/-), we analyzed the physiological and pathological roles of the endogenous AM gene. There were no differences in body size or heart and kidney weight compared with wild-type (AM +/+) mice. However, angiotensin II (Ang II) infusion resulted in more severe cardiac hypertrophy in AM +/- mice. The increases in the heart weight-to-body weight ratio and wall thickness of the left ventricle were more prominent in the AM +/- mice. Renal dysfunction characterized by decreased creatinine clearance (C(cr)) was more severe in AM +/- after Ang II infusion. These results suggest that AM plays critical roles in the defense mechanism against cardiac hypertrophy and renal dysfunction. An improved understanding of these roles may pave the way to a novel pharmacological approach for the prevention of cardiovascular diseases.
No takes yet. Share an insight, caveat, or question.
Niu et al. (2003) studied Cardiac hypertrophy and renal damage (n=80). Adrenomedullin heterozygote knockout (AM+/-) vs. Wild-type (AM+/+) was evaluated on Intraventricular septum thickness (IVST) after 14 days of Angiotensin II infusion (p=<0.01). Adrenomedullin heterozygote knockout mice exhibited more severe cardiac hypertrophy and renal dysfunction after Angiotensin II infusion compared to wild-type mice.
Synapse has enriched 10 related papers. Consider them for comparative context: